With more than 114,000 job cuts in the past two years, would you have predicted that the pharma industry constructed more than 85 plants and R&D facilitieis in 2010? This data comes from Industrial Info Resources.
The number of facilities is up from 76 facilities in 2009 and represents an investment of $7.1 B in 2010 (vs. $5.7 B in 2009). The average project size is $82.5 M. Notable projects include: Novartis' $1 B vaccine plant in Holly Springs, NC, Cannabis Sciences' $2.5 M to renovate R&D space, Dendreon's expansion of manufacturing capacity for Provenge in Atlanta, and Eli Lilly's animal health research center in Greenfield, IN.
Posted by Bruce Lehr Jan 4th 2011.